Inventor
Joshua Clayton
Inventor
Oakville, CA
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
A61KPreparations for medical, dental or toiletry purposes12%
C07CAcyclic or carbocyclic compounds5%
C07HSugars3%
Y02PClimate change mitigation technologies in the production or processing of goods3%
A61NElectrotherapy2%
C07BGeneral methods of organic chemistry2%
PatentTitleYear
11,058,882Implantable medical devices having circuitry located adjacent to header-related structures202110,344,018Pyrazolylaminobenzimidazole derivatives as JAK inhibitors201910,323,019Pyrazolylaminobenzimidazole derivatives as JAK inhibitors20199,556,153'JAK1 inhibitors'20179,403,864'Process for the synthesis of carbonucleoside and intermediates for use therein'20169,062,050'Inhibitor of JAK1 and JAK2'20158,658,792'Carbanucleoside synthesis and novel intermediate compounds useful therein'20148,513,441'Prostaglandin synthesis and intermediates for use therein'20138,436,002'AKT inhibitors'20138,377,940'Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842'20138,377,939'Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842'20138,309,744'Prostaglandin synthesis and intermediates for use therein'20128,153,638'Metabotropic glutamate-receptor-potentiating isoindolones'20128,058,425'Purine derivatives as kinase inhibitors'20117,968,570'Isoindolone compounds and their use as metabotropic glutamate receptor potentiators'20117,928,252'Prostaglandin synthesis and intermediates for use therein'20117,897,600'Amino pyrazole compound'20117,868,008'Substituted isoindolones and their use as metabotropic glutamate receptor potentiators'20117,816,354'Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators'20107,807,706'Metabotropic glutamate-receptor-potentiating isoindolones'20107,799,792'Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841'20107,790,717'Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators'20107,666,879'Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors'20107,485,722'Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators'20097,405,305'Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2019Patents assigned to LILLY CO ELI (9)· patent assignee history
2008–2011Based in Cicero, IN, US· patent location history
2009–2013Patents assigned to ASTRAZENECA AB (10)· patent assignee history
2009–2014Based in Oakville, CA· patent location history
2010–2019Based in Fishers, IN, US· patent location history
2010–2011Based in Toronto, CA· patent location history
2011–2016Patents assigned to ALPHORA RES INC (5)· patent assignee history
2012–2016Patents assigned to CLAYTON JOSHUA (7)· patent assignee history
2012–2016Patents assigned to ALBERICO DINO (4)· patent assignee history
2021Based in Zimmerman, MN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ASTRAZENECA AB | 10 | 2009–2013 |
| LILLY CO ELI | 9 | 2008–2019 |
| CLAYTON JOSHUAself | 7 | 2012–2016 |
| ALPHORA RES INC | 5 | 2011–2016 |
| ALBERICO DINO | 4 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oakville, CA | 11 | 2009–2014 |
| Fishers, IN, US | 7 | 2010–2019 |
| Cicero, IN, US | 2 | 2008–2011 |
| Toronto, CA | 2 | 2010–2011 |
| Zimmerman, Minnesota, US | 1 | 2021 |